132 related articles for article (PubMed ID: 37249325)
1. Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans-Atlantic, multicenter cross-sectional cohort study.
Hol MLF; Indelicato DJ; Slater O; Kolb F; Hewitt RJ; Ong J; Becking AG; Gains J; Bradley J; Sandler E; Gaze MN; Pieters B; Mandeville H; Fajardo RD; Schoot R; Merks JHM; Hammond P; Smeele LE; Suttie M
Pediatr Blood Cancer; 2023 Aug; 70(8):e30412. PubMed ID: 37249325
[TBL] [Abstract][Full Text] [Related]
2. Facial asymmetry in head and neck rhabdomyosarcoma survivors.
Schoot RA; Hol MLF; Merks JHM; Suttie M; Slater O; van Lennep M; Hopman SMJ; Dunaway D; Syme-Grant J; Smeele LE; Zwinderman KH; Caron HN; Hammond P
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28423221
[TBL] [Abstract][Full Text] [Related]
3. Endocrine disorders among long-term survivors of childhood head and neck rhabdomyosarcoma.
Clement SC; Schoot RA; Slater O; Chisholm JC; Abela C; Balm AJM; van den Brekel MW; Breunis WB; Chang YC; Davila Fajardo R; Dunaway D; Gajdosova E; Gaze MN; Gupta S; Hartley B; Kremer LCM; van Lennep M; Levitt GA; Mandeville HC; Pieters BR; Saeed P; Smeele LE; Strackee SD; Ronckers CM; Caron HN; van Santen HM; Merks JHM
Eur J Cancer; 2016 Feb; 54():1-10. PubMed ID: 26707591
[TBL] [Abstract][Full Text] [Related]
4. AMORE treatment as salvage treatment in children and young adults with relapsed head-neck rhabdomyosarcoma.
Vaarwerk B; Hol MLF; Schoot RA; Breunis WB; de Win MML; Westerveld H; Fajardo RD; Saeed P; van den Brekel MW; Pieters BR; Strackee SD; Smeele LE; Merks JHM
Radiother Oncol; 2019 Feb; 131():21-26. PubMed ID: 30773183
[TBL] [Abstract][Full Text] [Related]
5. Hearing loss in survivors of childhood head and neck rhabdomyosarcoma: a long-term follow-up study.
Schoot RA; Theunissen EA; Slater O; Lopez-Yurda M; Zuur CL; Gaze MN; Chang YC; Mandeville HC; Gains JE; Rajput K; Pieters BR; Davila Fajardo R; Talwar R; Caron HN; Balm AJ; Dreschler WA; Merks JH
Clin Otolaryngol; 2016 Jun; 41(3):276-83. PubMed ID: 26293165
[TBL] [Abstract][Full Text] [Related]
6. Adverse events of local treatment in long-term head and neck rhabdomyosarcoma survivors after external beam radiotherapy or AMORE treatment.
Schoot RA; Slater O; Ronckers CM; Zwinderman AH; Balm AJ; Hartley B; van den Brekel MW; Gupta S; Saeed P; Gajdosova E; Pieters BR; Gaze MN; Mandeville HC; Fajardo RD; Chang YC; Gains JE; Strackee SD; Dunaway D; Abela C; Mason C; Smeele LE; Chisholm JC; Levitt GA; Kremer LC; Grootenhuis MA; Maurice-Stam H; Stiller CA; Hammond P; Caron HN; Merks JH
Eur J Cancer; 2015 Jul; 51(11):1424-34. PubMed ID: 25998323
[TBL] [Abstract][Full Text] [Related]
7. The AMORE protocol as salvage treatment for non-orbital head and neck rhabdomyosarcoma in children.
Buwalda J; Blank LE; Schouwenburg PF; Copper MP; Strackee SD; Voûte PA; Merks JH; Caron HN
Eur J Surg Oncol; 2004 Oct; 30(8):884-92. PubMed ID: 15336736
[TBL] [Abstract][Full Text] [Related]
8. A novel local treatment strategy for advanced stage head and neck rhabdomyosarcomas in children: results of the AMORE protocol.
Buwalda J; Schouwenburg PF; Blank LE; Merks JH; Copper MP; Strackee SD; Voûte PA; Caron HN
Eur J Cancer; 2003 Jul; 39(11):1594-602. PubMed ID: 12855267
[TBL] [Abstract][Full Text] [Related]
9. Adult head and neck rhabdomyosarcoma: radiotherapy- based treatment, outcomes, and predictors of survival.
Zhao D; Zhou F; Liu W; Huang Z; Xu X; Zheng B; Liu C; Bai C; Liu J; Sun Y; Wang W; Xiao S
BMC Cancer; 2024 Mar; 24(1):340. PubMed ID: 38486204
[TBL] [Abstract][Full Text] [Related]
10. Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group.
Raney RB; Asmar L; Vassilopoulou-Sellin R; Klein MJ; Donaldson SS; Green J; Heyn R; Wharam M; Glicksman AS; Gehan EA; Anderson J; Maurer HM
Med Pediatr Oncol; 1999 Oct; 33(4):362-71. PubMed ID: 10491544
[TBL] [Abstract][Full Text] [Related]
11. Patient-reported outcomes in childhood head and neck rhabdomyosarcoma survivors and their relation to physician-graded adverse events-A multicenter study using the FACE-Q Craniofacial module.
Morfouace M; Hol MLF; Schoot RA; Slater O; Indelicato DJ; Kolb F; Smeele LE; Merks JHM; Rae C; Maurice-Stam H; Klassen AF; Grootenhuis MA
Cancer Med; 2023 Feb; 12(4):4739-4750. PubMed ID: 36208014
[TBL] [Abstract][Full Text] [Related]
12. Worse Outcomes for Head and Neck Rhabdomyosarcoma Secondary to Reduced-Dose Cyclophosphamide.
Casey DL; Wexler LH; Wolden SL
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1151-1157. PubMed ID: 30508617
[TBL] [Abstract][Full Text] [Related]
13. Late Toxicities of Intensity-Modulated Radiation Therapy for Head and Neck Rhabdomyosarcoma.
Lockney NA; Friedman DN; Wexler LH; Sklar CA; Casey DL; Wolden SL
Pediatr Blood Cancer; 2016 Sep; 63(9):1608-14. PubMed ID: 27195454
[TBL] [Abstract][Full Text] [Related]
14. Rhabdomyosarcoma of the head and neck in children: review and update.
Reilly BK; Kim A; Peña MT; Dong TA; Rossi C; Murnick JG; Choi SS
Int J Pediatr Otorhinolaryngol; 2015 Sep; 79(9):1477-83. PubMed ID: 26231745
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma.
Paulino AC; Simon JH; Zhen W; Wen BC
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1489-95. PubMed ID: 11121653
[TBL] [Abstract][Full Text] [Related]
16. Psychosocial well-being of long-term survivors of pediatric head-neck rhabdomyosarcoma.
Vaarwerk B; Schoot RA; Maurice-Stam H; Slater O; Hartley B; Saeed P; Gajdosova E; van den Brekel MW; Balm AJM; Hol MLF; van Jaarsveld S; Kremer LCM; Ronckers CM; Mandeville HC; Pieters BR; Gaze MN; Davila Fajardo R; Strackee SD; Dunaway D; Smeele LE; Chisholm JC; Caron HN; Grootenhuis MA; Merks JHM
Pediatr Blood Cancer; 2019 Feb; 66(2):e27498. PubMed ID: 30318743
[TBL] [Abstract][Full Text] [Related]
17. The AMORE protocol for advanced-stage and recurrent nonorbital rhabdomyosarcoma in the head-and-neck region of children: a radiation oncology view.
Blank LE; Koedooder K; Pieters BR; van der Grient HN; van de Kar M; Buwalda J; Balm AJ; Merks JH; Strackee SD; Freling NJ; Koning CC
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1555-62. PubMed ID: 19250759
[TBL] [Abstract][Full Text] [Related]
18. Pediatric head and neck rhabdomyosarcoma: An analysis of treatment and survival in the United States (1975-2016).
Darwish C; Shim T; Sparks AD; Chillakuru Y; Strum D; Benito DA; Monfared A
Int J Pediatr Otorhinolaryngol; 2020 Dec; 139():110403. PubMed ID: 33049553
[TBL] [Abstract][Full Text] [Related]
19. Proton radiotherapy for parameningeal rhabdomyosarcoma: clinical outcomes and late effects.
Childs SK; Kozak KR; Friedmann AM; Yeap BY; Adams J; MacDonald SM; Liebsch NJ; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):635-42. PubMed ID: 21377294
[TBL] [Abstract][Full Text] [Related]
20. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.
Michalski JM; Meza J; Breneman JC; Wolden SL; Laurie F; Jodoin M; Raney B; Wharam MD; Donaldson SS
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1027-38. PubMed ID: 15234036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
